100 related articles for article (PubMed ID: 18714562)
1. Peri- and intratumoral T and B lymphocytic infiltration in breast cancer.
Menegaz RA; Michelin MA; Etchebehere RM; Fernandes PC; Murta EF
Eur J Gynaecol Oncol; 2008; 29(4):321-6. PubMed ID: 18714562
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: relation to prognostic variables.
Helal TE; Ibrahim EA; Alloub AI
Indian J Pathol Microbiol; 2013; 56(2):89-93. PubMed ID: 24056641
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of B-cell density in cutaneous melanoma.
Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors for Breast Cancer: an Immunomorphological Update.
Roncati L; Barbolini G; Piacentini F; Piscioli F; Pusiol T; Maiorana A
Pathol Oncol Res; 2016 Jul; 22(3):449-52. PubMed ID: 26589512
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.
Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M
Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657
[TBL] [Abstract][Full Text] [Related]
6. Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast.
Coronella JA; Spier C; Welch M; Trevor KT; Stopeck AT; Villar H; Hersh EM
J Immunol; 2002 Aug; 169(4):1829-36. PubMed ID: 12165506
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast.
Xu Y; Lan S; Zheng Q
Tumori; 2018 Jun; 104(3):196-201. PubMed ID: 28430349
[TBL] [Abstract][Full Text] [Related]
8. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
Ziai J; Gilbert HN; Foreman O; Eastham-Anderson J; Chu F; Huseni M; Kim JM
PLoS One; 2018; 13(1):e0190158. PubMed ID: 29320521
[TBL] [Abstract][Full Text] [Related]
10. Assessment of tumor-associated immune cells in laryngeal squamous cell carcinoma.
Zhou L; Li Y; Gao W; Huangfu H; Wen S; Zhang C; Zhao Q; Dong Z; Qu C; Li G; Wu L; Wang B
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1761-1772. PubMed ID: 31115672
[TBL] [Abstract][Full Text] [Related]
11. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast.
Kuroda H; Tamaru J; Sakamoto G; Ohnisi K; Itoyama S
Virchows Arch; 2005 Jan; 446(1):10-4. PubMed ID: 15660281
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ.
Miligy I; Mohan P; Gaber A; Aleskandarany MA; Nolan CC; Diez-Rodriguez M; Mukherjee A; Chapman C; Ellis IO; Green AR; Rakha EA
Histopathology; 2017 Aug; 71(2):258-268. PubMed ID: 28326600
[TBL] [Abstract][Full Text] [Related]
14. Local inflammatory response in colorectal cancer.
Łaskowski P; Klim B; Ostrowski K; Szkudlarek M; Litwiejko-Pietryńczak E; Kitlas K; Nienartowicz S; Dzięcioł J
Pol J Pathol; 2016 Jun; 67(2):163-71. PubMed ID: 27543872
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer.
Mani NL; Schalper KA; Hatzis C; Saglam O; Tavassoli F; Butler M; Chagpar AB; Pusztai L; Rimm DL
Breast Cancer Res; 2016 Jul; 18(1):78. PubMed ID: 27473061
[TBL] [Abstract][Full Text] [Related]
16. Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer.
Miyan M; Schmidt-Mende J; Kiessling R; Poschke I; de Boniface J
J Transl Med; 2016 Jul; 14(1):227. PubMed ID: 27473163
[TBL] [Abstract][Full Text] [Related]
17. Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.
Ladoire S; Arnould L; Apetoh L; Coudert B; Martin F; Chauffert B; Fumoleau P; Ghiringhelli F
Clin Cancer Res; 2008 Apr; 14(8):2413-20. PubMed ID: 18413832
[TBL] [Abstract][Full Text] [Related]
18. The composition of T cell infiltrates varies in primary invasive breast cancer of different molecular subtypes as well as according to tumor size and nodal status.
Glajcar A; Szpor J; Hodorowicz-Zaniewska D; Tyrak KE; Okoń K
Virchows Arch; 2019 Jul; 475(1):13-23. PubMed ID: 31016433
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 10-expressing B cells inhibit tumor-infiltrating T cell function and correlate with T cell Tim-3 expression in renal cell carcinoma.
Cai C; Zhang J; Li M; Wu ZJ; Song KH; Zhan TW; Wang LH; Sun YH
Tumour Biol; 2016 Jun; 37(6):8209-18. PubMed ID: 26715281
[TBL] [Abstract][Full Text] [Related]
20. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
